MEDLINEplus^® Drug Information

U.S. Preparations:

• Abilify^® (Bristol-Myers Squibb) FDA approved for treatment of:
  11.15.2002 Schizophrenia
  8.28.2003 Schizophrenia including maintenance up to 26 weeks
  9.29.2004 Acute manic or mixed episodes associated with Bipolar Disorder
  3.1.2005 Maintenance therapy in Bipolar I Disorder
  9.20.2006 (intramuscular) agitation associated with Schizophrenia or Bipolar Disorder, manic or mixed
  10.29.2007 treatment of Schizophrenia in adolescents aged 13-17
  11.16.2007 adjunctive treatment of Major Depressive Disorder
  2.27.2008 treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults and pediatric patients aged 10 to 17 years
  5.6.2008 adjunctive therapy added to lithium or valproate in the short-term treatment of  episodes associated with Bipolar Disorder, manic or mixed
  US prescribing information

• Abilify^® Discmelt™ (Otsuka) FDA approved for treatment of :
  6.7.2006 Schizophrenia; acute manic or mixed episodes associated with Bipolar Disorder
  10.29.2007 treatment of Schizophrenia in adolescents aged 13-17
  11.16.2007 adjunctive treatment of Major Depressive Disorder
  US prescribing information

Other Preparations:

• Abilitat

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2010 BehaveNet®